Loring Wolcott & Coolidge Fiduciary Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.8M | Sell |
332,735
-4,294
| -1% | -$503K | 0.42% | 48 |
|
|
2026
Q1 | $40.9M | Sell |
337,029
-7,979
| -2% | -$921K | 0.41% | 47 |
|
|
2025
Q4 | $37.2M | Sell |
345,008
-18,793
| -5% | -$1.76M | 0.34% | 51 |
|
|
2025
Q3 | $31.7M | Sell |
363,801
-15,259
| -4% | -$1.26M | 0.28% | 55 |
|
|
2025
Q2 | $30M | Sell |
379,060
-14,614
| -4% | -$1.16M | 0.27% | 55 |
|
|
2025
Q1 | $31M | Sell |
393,674
-12,871
| -3% | -$1.2M | 0.3% | 53 |
|
|
2024
Q4 | $39.8M | Sell |
406,545
-9,219
| -2% | -$950K | 0.34% | 50 |
|
|
2024
Q3 | $44M | Sell |
415,764
-3,211
| -0.8% | -$381K | 0.39% | 49 |
|
|
2024
Q2 | $52.6M | Sell |
418,975
-2,844
| -0.7% | -$366K | 0.48% | 45 |
|
|
2024
Q1 | $53.5M | Sell |
421,819
-5,271
| -1% | -$650K | 0.53% | 42 |
|
|
2023
Q4 | $51.6M | Sell |
427,090
-3,439
| -0.8% | -$357K | 0.51% | 44 |
|
|
2023
Q3 | $44.3M | Sell |
430,529
-3,155
| -0.7% | -$340K | 0.5% | 45 |
|
|
2023
Q2 | $50M | Sell |
433,684
-4,344
| -1% | -$493K | 0.53% | 41 |
|
|
2023
Q1 | $46.6M | Sell |
438,028
-4,118
| -0.9% | -$445K | 0.53% | 41 |
|
|
2022
Q4 | $49.1M | Sell |
442,146
-805
| -0.2% | -$82.3K | 0.61% | 40 |
|
|
2022
Q3 | $38.1M | Sell |
442,951
-962
| -0.2% | -$85.9K | 0.5% | 46 |
|
|
2022
Q2 | $40.5M | Sell |
443,913
-2,153
| -0.5% | -$191K | 0.5% | 46 |
|
|
2022
Q1 | $36.6M | Buy |
446,066
+10,507
| +2% | +$828K | 0.38% | 51 |
|
|
2021
Q4 | $33.4M | Buy |
435,559
+7,799
| +2% | +$621K | 0.31% | 53 |
|
|
2021
Q3 | $32.1M | Buy |
427,760
+11,446
| +3% | +$871K | 0.32% | 52 |
|
|
2021
Q2 | $32.4M | Buy |
416,314
+30,291
| +8% | +$2.25M | 0.33% | 53 |
|
|
2021
Q1 | $28.4M | Buy |
386,023
+64,493
| +20% | +$4.76M | 0.31% | 53 |
|
|
2020
Q4 | $25.1M | Buy |
321,530
+14,305
| +5% | +$1.09M | 0.28% | 54 |
|
|
2020
Q3 | $24.3M | Buy |
307,225
+37,422
| +14% | +$2.93M | 0.31% | 53 |
|
|
2020
Q2 | $19.9M | Buy |
269,803
+170,434
| +172% | +$12.8M | 0.27% | 55 |
|
|
2020
Q1 | $7.29M | Buy |
99,369
+27
| +0% | +$2.12K | 0.12% | 65 |
|
|
2019
Q4 | $8.62M | Sell |
99,342
-1,067
| -1% | -$87.6K | 0.12% | 69 |
|
|
2019
Q3 | $8.06M | Buy |
100,409
+3,467
| +4% | +$278K | 0.12% | 68 |
|
|
2019
Q2 | $7.76M | Buy |
96,942
+2,631
| +3% | +$201K | 0.11% | 73 |
|
|
2019
Q1 | $7.49M | Sell |
94,311
-1,946
| -2% | -$146K | 0.11% | 79 |
|
|
2018
Q4 | $7.02M | Buy |
96,257
+1,736
| +2% | +$123K | 0.13% | 80 |
|
|
2018
Q3 | $6.4M | Sell |
94,521
-27
| -0% | -$1.72K | 0.1% | 86 |
|
|
2018
Q2 | $5.48M | Buy |
94,548
+167
| +0.2% | +$9.42K | 0.1% | 87 |
|
|
2018
Q1 | $4.91M | Sell |
94,381
-5,061
| -5% | -$273K | 0.09% | 93 |
|
|
2017
Q4 | $5.34M | Sell |
99,442
-365
| -0.4% | -$20.2K | 0.1% | 91 |
|
|
2017
Q3 | $6.1M | Buy |
99,807
+1,312
| +1% | +$79.5K | 0.12% | 86 |
|
|
2017
Q2 | $6M | Sell |
98,495
-1,117
| -1% | -$68K | 0.12% | 86 |
|
|
2017
Q1 | $6.04M | Sell |
99,612
-446
| -0.4% | -$27.1K | 0.13% | 85 |
|
|
2016
Q4 | $5.62M | Buy |
100,058
+367
| +0.4% | +$21.5K | 0.13% | 89 |
|
|
2016
Q3 | $5.94M | Buy |
99,691
+3,069
| +3% | +$179K | 0.14% | 86 |
|
|
2016
Q2 | $5.31M | Buy |
96,622
+11,310
| +13% | +$602K | 0.12% | 90 |
|
|
2016
Q1 | $4.31M | Sell |
85,312
-2,705
| -3% | -$132K | 0.1% | 95 |
|
|
2015
Q4 | $4.44M | Buy |
88,017
+2,038
| +2% | +$103K | 0.11% | 96 |
|
|
2015
Q3 | $4.67M | Hold |
85,979
| – | – | 0.12% | 89 |
|
|
2015
Q2 | $4.67M | Sell |
85,979
-1,922
| -2% | -$108K | 0.12% | 89 |
|
|
2015
Q1 | $4.82M | Sell |
87,901
-2,258
| -3% | -$128K | 0.12% | 88 |
|
|
2014
Q4 | $4.89M | Sell |
90,159
-387
| -0.4% | -$21.6K | 0.13% | 89 |
|
|
2014
Q3 | $5.12M | Sell |
90,546
-525
| -0.6% | -$29.5K | 0.14% | 89 |
|
|
2014
Q2 | $5.03M | Sell |
91,071
-582
| -0.6% | -$31.8K | 0.14% | 86 |
|
|
2014
Q1 | $4.96M | Buy |
91,653
+120
| +0.1% | +$6.21K | 0.14% | 92 |
|
|
2013
Q4 | $4.37M | Buy |
91,533
+1,000
| +1% | +$45.7K | 0.12% | 94 |
|
|
2013
Q3 | $4.11M | Sell |
90,533
-5,876
| -6% | -$268K | 0.13% | 95 |
|
|
2013
Q2 | $4.27M | Buy |
+96,409
| New | +$4.31M | 0.13% | 97 |
|
Other funds holding MRK
Loring Wolcott & Coolidge Fiduciary Advisors's MRK Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $503K and leaving 332,735 shares worth $42.8M. The position accounts for 0.42% of the portfolio, ranked #48.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $53.5M in Q1 2024. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 332,735 shares of Merck worth $42.8M as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 4,294 Merck shares in Q2 2026, an estimated $503K.
- Merck made up 0.42% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #48 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's Merck position peaked at $53.5M in Q1 2024.
- 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.